Food and Drug Administration issued a warning that versions of semaglutide obtained from compounding pharmacies could be dangerous
doi: 10.1152/ajplung.1999.277.6.L1142 124 PostMBarsoumianASmithBT
This suggests that semaglutide could potentially accelerate metabolism, reduce weight gain, and improve insulin sensitivity, all of which help with weight loss
FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances
Participants also saw improvements in waist circumference, blood pressure, and overall physical fitness